CONy 2024 | Exciting remyelination research in MS: cell therapy and neuromodulation

In patients with multiple sclerosis (MS), it is important to not only focus on preventing disease-related damage through disease-modifying treatment, but also to explore methods to enhance the recovery of patients following attacks. Giancarlo Comi, MD, Vita-Salute San Raffaele University, Milan, Italy, discusses the current research into promoting remyelination in patients with MS. Several ongoing Phase II trials are investigating the possibility of stimulating remyelination, and recently, an observation has been made that cellular therapies may play a role in this. Additionally, neuromodulation, the use of magnetic or electrical stimulation of the central nervous system (CNS) to enhance the mechanism of plasticity, may be an effective approach for enhancing the natural recovery capacity of the nervous system. This interview took place at the 18th Annual Congress on Controversies in Neurology (CONy 2024) in London, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.